SCHEMBL5507539

SCHEMBL5507539

Clc1ccc([AsH2])nc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL197456 0.71 CCR1 (0.46) —
SCHEMBL17800 0.71 — —
SCHEMBL31504098 0.71 CCR1 (0.46) —
SCHEMBL29538085 0.71 — —
SCHEMBL32681750 0.69 — —
Ammonia Solution, Strong SCHEMBL14636438 0.69 — —
SCHEMBL1017992 0.67 PTK2 (0.38) —
SCHEMBL1311357 0.67 — —
SCHEMBL18403109 0.67 — —
SCHEMBL132151 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814855-A2 DICARBOXAMIDE DERIVATIVES AND THEIR USE AS FACTOR XA INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2007-08-08 — — EP disclosed
WO-2006048152-A2 DICARBOXAMIDE DERIVATIVES AND THEIR USE AS FACTOR XA INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2006-05-11 — — WO disclosed
Send feedback